Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Can't Halt Janssen's Promo Comparing Their Psoriasis Drugs

Mar 06 2019

• By Brenda Sandburg

Mannheim, Germany - April 5, 2018: Poster presentation at the German cardiologist congress in Mannheim — Novartis says that Janssen is distributing misleading brochures at medical conferences.

Related Content

Carry On Cosentyx As Novartis Lines Up More Blockbusters

Jan 30 2019

ECLIPSE: J&J's Tremfya Beats Novartis' Cosentyx For Long-Term Psoriasis Clearance

Dec 13 2018

'Off-Label' Communications That Are Still 'Consistent' With Labeling Get Better Defined

Jun 13 2018

Related Companies

Novartis AG

Johnson & Johnson

GSK plc

Johnson & Johnson

Additional Topics

United States Legal Issues Advertising, Marketing & Sales Ad Campaigns Policy Immune Disorders BioPharmaceutical

More from Legal & IP

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window